For example, the m6A level of CCR2 (a chemokine receptor) is markedly elevated in the progression of liver fibrosis, while decreased in the reversal of liver fibrosis, indicating its potential as a therapeutic target [72]. This evidence concerns the gene CCR2 and Hepatic fibrosis.